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MicroRNA-21 and programmed cell death 4 (PDCD4), a downstream target of miR-21, mediate
diverse physiological responses. Here we demonstrate that globular adiponectin (gAcrp) modulates
expression of miR-21 and PDCD4 in RAW 264.7 macrophages. These effects were abrogated by inhib-
itors of ERK1/2, JNK or NF-jB. Conditioned media collected from gAcrp-stimulated RAW 264.7 mac-
rophages caused similar effects as direct gAcrp treatment, showing the paracrine effect of gAcrp.
These data indicate that gAcrp modulates the miR-21/PDCD4 axis through the ERK and JNK/NF-jB
pathways in RAW 264.7 macrophages and further suggest that the miR-21/PDCD4 axis may be a
novel target mediating adiponectin-induced biological responses.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Adiponectin, an adipokine predominantly secreted from adi-
pose tissue, plays an important role in various physiological pro-
cesses including lipid metabolism, insulin sensitization and anti-
inﬂammatory response [1]. However, its underlying molecular
mechanisms have not been clearly characterized.
MicroRNAs (miRNAs), a family of small non-coding RNAs, con-
trol expression of target genes at post-transcriptional level by
destabilizing mRNA or inhibiting translation and are involved in
a wide array of biological functions [2]. Particularly, a growing
body of evidence has highlighted that miRNAs regulate the im-
mune response by regulating the expressions of various target
genes associated with the inﬂammatory response, such as tumor
necrosis factor-a (TNF-a), interleukin-10 and programmed cell
death 4 [3–6]. A recent report suggested that miRNAs regulated
by adiponectin act as mediators for anti-inﬂammatory action in
adipose tissue [7]. However, the roles of miRNAs in the anti-inﬂammatory responses by adiponectin and the mechanisms
underlying regulation of miRNAs by adiponectin have not been
demonstrated yet.
Programmed cell death 4 (PDCD4) suppresses expression of var-
ious target genes through inhibition of cap-dependent mRNA
translation by interacting with translation initiation factors, such
as eIF4A and eIF4G [8,9], as well as by acting at the transcriptional
level [10,11]. PDCD4 has long been considered as a tumor suppres-
sor protein [11]. In addition, recent studies have also shown that
PDCD4 knockout mice are less susceptible to LPS toxicity [6] and
are resistant to inﬂammatory disease [9] suggesting that PDCD4
possesses potent pro-inﬂammatory properties [6,9]. MicroRNAs
play an important role in the regulation of PDCD4 expression. In
particular, emerging evidence suggest that PDCD4 expression is
negatively regulated by miR-21 [6,8,10,12,13].
After careful analysis of previous reports we found that miR-21/
PDCD4 axis and adiponectin shares various biological responses in
common. However, the relationship between adiponectin and the
miR-21/PDCD4 axis has not been explored. In the present study,
we investigated the effect of globular adiponectin on the expres-
sion of PDCD4 and miR-21 in RAW 264.7 macrophages and further
its potential mechanisms. Here we demonstrate for the ﬁrst time
A. Subedi et al. / FEBS Letters 587 (2013) 1556–1561 1557that globular adiponectin decreases expression of PDCD4 and in-
creases miR-21 via ERK and JNK/NF-jB pathways in RAW 264.7
macrophages.
2. Materials and methods
2.1. Materials
Recombinant human gAcrp expressed in Escherichia coli was
purchased from Peprotech, Inc. (Rocky Hill, NJ, USA) and stock
solutions were prepared by diluting in PBS. All cell culture reagents
were purchased from Hyclone Laboratories (South Logan, UT, USA).
Bay 11-7082, an inhibitor of NF-jB, was purchased from Sigma–Al-
drich (St. Louis, MO, USA). SB 203580 and SP600125 were from To-
cris Bioscience (Bristol, UK). U0126 and PDCD4 monoclonal
antibody were from Cell Signaling (Danvers, MA, USA).
2.2. Culture of RAW 264.7 macrophages
Murine RAW 264.7 macrophages were purchased from the Kor-
ean Cell Line Bank (Seoul, Korea) and routinely cultured in Dul-
becco’s Modiﬁed Eagle Medium supplemented with 10% FBS and
1% penicillin–streptomycin at 37 C and 5% CO2 in an incubator
with a humidiﬁed atmosphere.
2.3. Quantitative real time-PCR (qPCR)
Total RNA was extracted and reverse transcribed as described
previously [14]. Real Time PCR ampliﬁcation was then performed
using absolute QPCR SYBR Green Capillary Mix in Roche Lightcycler
1.5 (Roche, Mannheim, Germany). GAPDH was used as internal
control. The primer sequences used were as follows: GAPDH – 50-
ACCACAGTCCATGCCATC-30 (sense) and 50-TCCACCACCCTGTTGCT-
GTA-30 (antisense) and PDCD4 – 50-TAATCAGTGCAAGCGAAAT-
TAAGGAA-30 (sense) and 50-CCTTTCCCAGATCTGGACCGCCTATC-30
(antisense). For the measurement of miRNA levels, total RNA was
reverse transcribed using miScript II RT Kit (Qiagen) and ampliﬁed
using miScript SYBR Green PCR Kit (Qiagen) according to the man-
ufacturer’s instructions. The primers for miRNA were predesigned
and purchased as miScript Primer Assay (Qiagen) and RNU6B
was used as an internal control. The amount of target mRNA and
miRNA were determined via comparative threshold (Ct) method
after normalizing target mRNA’s or miRNA’s Ct values to those
for GAPDH or RNU6B (DCt).
2.4. Western blot analysis
PDCD4 protein expression were measured essentially as de-
scribed previously [14]. Brieﬂy, total proteins were isolated using
RIPA Lysis buffer containing protease inhibitors cocktail, separated
in 10% SDS–PAGE and transferred onto PVDF membrane. The mem-
branes were incubated with primary antibody and secondary anti-
body conjugated with horseradish peroxidase and then visualized
by chemiluminescent substrate. b-actin was used as internal
control.
2.5. Preparation of conditioned media
For preparation of conditioned media, RAW 264.7 macrophages
were stimulated with 1 lg/ml of gAcrp for 8 h, washed and then
incubated for 12 h in the absence of gAcrp. Supernatants were then
collected as conditioned media (CM).The conditioned media were
mixed with fresh media at 2:1 ratio and used for treatment of
RAW 264.7 macrophages. All conditioned media were freshly pre-
pared before use. Media collected from the cells treated with med-
ia alone (DMEM + 0.1% FBS) in the absence of gAcrp were used as
the control group.2.6. Statistical analysis
Values are expressed as mean ± S.E.M. from at least three inde-
pendent experiments. Data were analyzed by one-way analysis of
variance (ANOVA) and Tukey’s multiple comparison tests using
GraphPad Prism 5.01 (California, USA). Differences between groups
were considered statistically signiﬁcant at P < 0.05.
3. Results
3.1. Globular adiponectin inhibits PDCD4 expression in RAW 264.7
macrophages
To investigate the relationship betweenmiR-21/PDCD4 axis and
adiponectin, we ﬁrst examined the effect of globular adiponectin
(gAcrp) on PDCD4 expression in RAW 264.7 macrophages. As
shown in Fig. 1, gAcrp signiﬁcantly inhibited mRNA expression of
PDCD4 in a dose-dependent manner showing a signiﬁcant effect
even at very low concentration (0.01 lg/ml) (Fig. 1A) and in a
time-dependent manner (Fig. 1B). Furthermore, gAcrp treatment
induced a signiﬁcant decrease in PDCD4 protein expression in a
dose- and time-dependent manner (Fig. 1C and D) similar to the
pattern of mRNA expression. However, this effect was not apparent
in different types of cells, including human hepatoma cells
(HepG2) (Fig. 1C, right panel) and human intestinal epithelial cell
line (HT-29) (data not shown), indicating that gAcrp regulates
PDCD4 expression in a cell speciﬁc manner. Globular adiponectin
used for these experiments was prepared from E. coli. To exclude
the possibility that endotoxin contamination contributed to al-
tered expression of PDCD4, cells were pretreated with polymyxin
B, an antibiotic that inactivates LPS, prior to stimulation with LPS
or gAcrp. While polymyxin B prevented PDCD4 suppression by
LPS, it had no effect on PDCD4 suppression by gAcrp (Fig. 1E).3.2. Globular adiponectin increases miR-21 expression in RAW 264.7
macrophages
MicroRNA-21 is widely known to negatively regulate PDCD4
expression [6,8,10,12]. To investigate whether miR-21 is impli-
cated in the suppression of PDCD4 by gAcrp, cells were treated
with gAcrp under the same conditions as measurement of PDCD4
expression and miR-21 expression level was examined by qRT-
PCR. As depicted in Fig. 2, gAcrp treatment induced expression of
miR-21 in a dose- (Fig. 2A) and time-dependent manner, showing
a maximal about 7-fold increase (Fig. 2B).3.3. ERK and JNK/NF-jB pathways are implicated in the modulation of
miR-21 and PDCD4 expression by gAcrp
We further investigated the signaling pathways involved in
gAcrp-induced expression of miR-21. Previous studies have shown
that activation of NF-jB induces expression of miR-21 [6] and gAc-
rp has been shown to increase the transcriptional activity of NF-jB
[15]. Thus, we examined the role of NF-jB in gAcrp-induced miR-
21 expression. As shown in Fig. 3A, Bay 11-7082, an inhibitor of
IjB-a phosphorylation, partially but signiﬁcantly reduced gAcrp-
induced miR-21 expression, indicating that NF-jB is, at least in
part, involved in the expression of miR-21 by gAcrp. Since MAPKs
are widely known to activate NF-jB and gAcrp has been previously
shown to rapidly activate MAPKs [16], we further examined the
role of MAPK signaling for the identiﬁcation of upstream signaling
pathways. Pretreatment with inhibitors of ERK1/2 or JNK (U0126
and SP600125) signiﬁcantly abolished gAcrp-induced miR-21
expression in a dose dependent manner while p38 MAPK inhibi-
tor (SB203580) had no signiﬁcant effect (Fig. 3B). In addition,
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Fig. 1. Effect of globular adiponectin on PDCD4 expression in RAW 264.7
macrophages. Cells were treated with the indicated concentration of gAcrp for
16 h (A) or treated for the indicated time with 1 lg/ml of gAcrp (B). PDCD4 mRNA
level was measured by qRT-PCR as described in materials and methods. Values
represent fold increase compared to control and are expressed as mean ± S.E.M.
(n = 3). ⁄P < 0.05 compared with cells not treated with adiponectin. RAW 264.7
macrophages or HepG2 cells were treated with indicated concentration of gAcrp for
24 h (C) or treated for the indicated time with 1 lg/ml of gAcrp (D). PDCD4 protein
level was determined by Western blot analysis. Images are representative of three
independent experiments that showed similar results. (E) Cells were pretreated
with polymyxinB (PMB) for 1 h followed by stimulation with gAcrp or LPS for 3 h
and PDCD4 mRNA level was measured. #P < 0.05 compared with cells not treated
with PMB.
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Fig. 2. Effect of globular adiponectin on miR-21 expression in RAW 264.7
macrophages. Cells were treated with the indicated concentration of gAcrp for
16 h (A) or the indicated time periods with 1 lg/ml of gAcrp (B). MiR-21 level was
measured by qRT-PCR and normalized to RNU6B. Values represent fold increase
compared to control and are expressed as mean ± S.E.M. (n = 3). ⁄P < 0.05 compared
with cells not treated with adiponectin.
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of PDCD4 expression by gAcrp (Fig. 3C). Further, ERK1/2 and JNK
inhibitors also reverted suppression of PDCD4 mRNA (Fig. 3D)
and protein expression (Fig. 3E) by gAcrp in a dose dependent
manner, while inhibition of p38 MAPK had no signiﬁcant effect(Fig. 3D and E), which is similar to the regulation of miR-21. In
these experiments, combined inhibition of JNK and ERK1/2 gener-
ated synergistic effects on modulation of miR-21 and PDCD4
expression compared with individual inhibition (Fig. 3B, D and
E), implying that JNK and ERK1/2 signaling pathways are parallel
to each other, rather than upstream or downstream to each other.
3.4. Globular adiponectin regulates expression of miR-21 and PDCD4
in a paracrine manner
Adiponectin has been shown to induce a number of biological
responses in a paracrine manner. For example, the anti-inﬂamma-
tory response of adiponectin is mediated by stimulating secretion
of various mediators involved in inﬂammatory response [15]. To
determine whether gAcrp utilizes paracrine manner in the modu-
lation of miR-21 and PDCD4, we prepared conditioned media col-
lected from RAW 264.7 macrophages stimulated with gAcrp and
investigated its effects on the expression of miR-21 and PDCD4.
As shown in Fig. 4A and B, treatment of cells with conditioned
media also decreased PDCD4 expression at both protein and mRNA
levels and increased miR-21 expression (Fig. 4C) similar to the ef-
fects by direct gAcrp treatment, suggesting that gAcrp modulates
expression of PDCD4 and miR-21 in a paracrine manner. However,
conditioned media did not produce signiﬁcant effect on PDCD4
expression in HepG2 cells (Fig. 4A, right panel).
3.5. Paracrine modulation of miR-21 and PDCD4 expression by gAcrp
involves JNK/NF-jB pathways
To further investigate the signaling pathways involved in para-
crine effect of gAcrp, we examined the role of MAPK signaling in
miR-21 and PDCD4 expression modulated by paracrine manner.
As shown in Fig. 5A and B, treatment with conditioned media
(CM) prepared from RAW 264.7 macrophages treated with JNK or
NF-jB inhibitor restored suppression of PDCD4 expression, while
CM prepared from ERK1/2 inhibitor very slightly restored PDCD4
suppression and CM from p38 MAPK inhibitor did not produce
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Fig. 3. Involvement of MAPK/NF-jB pathway in modulation of miR-21 and PDCD4 expression by gAcrp. Cells were pretreated with Bay 11-7082, a selective inhibitor of NF-jB
(A) or with selective inhibitors of MAPK (B) for 1 h followed by stimulation with gAcrp for additional 16 h. MiR-21 level was measured as described previously. Values
represent fold increase compared to the cells treated with gAcrp and are expressed as mean ± S.E.M. (n = 3). ⁄P < 0.05 compared with cells treated with adiponectin, #P < 0.05
compared with cells treated with U0126 or SP600125 alone. (C) Cells were pretreated with Bay 11-7082 for 1 h followed by stimulation with gAcrp for additional 24 h. PDCD4
protein level was determined by Western blot analysis. (D) Cells were pretreated with an inhibitor of MAPK for 1 h followed by stimulation with gAcrp for additional 16 h.
PDCD4 mRNA level was measured by qRT-PCR. Values represent fold increase compared to control and are expressed as mean ± S.E.M. (n = 4–5). ⁄P < 0.05 compared with cells
not treated with adiponectin, #P < 0.05 compared with cells treated with adiponectin, $P < 0.05 compared with U0126 or SP600125 alone. (E) Cells were pretreated with MAPK
inhibitors for 1 h followed by stimulation with gAcrp for additional 24 h. PDCD4 protein level was determined by Western blot analysis.
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pathway, but not ERK1/2 and p38 MAPK, mediates paracrine sup-
pression of PDCD4 by gAcrp. Involvement of JNK signaling, but not
ERK, in paracrine effect by gAcrp was conﬁrmed in miR-21 expres-
sion (Fig. 5C). These results indicate that ERK signaling, may not
play a role in paracrine modulation of miR-21/PDCD4 by gAcrp,
though it play a role in direct action of gAcrp on the modulation
of miR-21 and PDCD4.4. Discussion
Adiponectin, a fat tissue-derived adipokine, plays a protective
role in various pathophysiological conditions. In addition to its
well-characterized role in lipid metabolism and insulin sensitizing
effect, recent studies have suggested that adiponectin possesses
potent anti-inﬂammatory and anti-tumor activity. PDCD4, acting
as a suppressor of various target genes, has been considered as a
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β-actin
CM-8AControl CM-U CM-8B Control CM-U CM-8B
RAW 264.7 HepG2
Control     CM-U     CM-8A
*
Control    CM-U     CM-8A
*
A
B C
Fig. 4. Paracrine effects of gAcrp on miR-21 and PDCD4 expression. Conditioned
media (CM) were prepared as described in Section 2 and treated with cells for 24 h.
(A) PDCD4 protein level was determined in RAW 264.7 macrophages and HepG2
cells by Western blot analysis. Images are representative of three independent
experiments. (B) PDCD4 mRNA level was measured by qRT-PCR. Values represent
fold increase compared to control and are expressed as mean ± S.E.M. (n = 3). (C)
MiR-21 level was measured by qRT-PCR. Values represent fold increase compared
to control and are expressed as mean ± S.E.M. (n = 4). ⁄P < 0.05 compared with cells
treated with DMEM containing 0.1% FBS (Control). CM-U: CM prepared from
unstimulated cells; CM-8A: CM prepared from cells stimulated with gAcrp for 8 h
and further incubated for 12 h in the absence of gAcrp. CM-8B: CM prepared from
cells stimulated with gAcrp for 8 h and further incubated for 24 h in the absence of
gAcrp.
SB 203580 (20 μM) 
SP 600125 (25 μM) 
Bay 11-7082 (10 μM) 
CM 
U 0126 (10 μM) 
+ 
- 
- 
- 
- 
+ 
+ 
- 
- 
- 
+ 
- 
- 
+ 
- 
+ 
- 
+ 
- 
- 
- 
- 
- 
- 
- 
+ 
- 
- 
- 
+ 
PDCD4 
β-actin 
SB 203580 (20 μM) 
SP 600125 (25 μM) 
Bay 11-7082 (10 μM) 
CM 
U 0126 (10 μM) 
+ 
- 
- 
- 
- 
+ 
+ 
- 
- 
- 
+ 
- 
- 
+ 
- 
+ 
- 
+ 
- 
- 
- 
- 
- 
- 
- 
+ 
- 
- 
- 
+ 
0.0
0.5
1.0
PD
C
D
4/
G
AP
D
H
(fo
ld
 o
ve
r 
ba
sa
l)
# # 
* 
SB 203580 (20 μM) 
SP 600125 (25 μM) 
Bay 11-7082 (10 μM) 
CM 
U 0126 (10 μM) 
+ 
- 
- 
- 
- 
+ 
+ 
- 
- 
- 
+ 
- 
- 
+ 
- 
+ 
- 
+ 
- 
- 
- 
- 
- 
- 
- 
+ 
- 
- 
- 
+ 
0.0
0.5
1.0
m
iR
-2
1/
R
N
U
6B
(fo
ld
 o
ve
r 
C
M
)
# # 
* 
A
B
C
Fig. 5. Role of JNK/NF-jB pathway in paracrine modulation of miR-21 and PDCD4
expression by gAcrp. CM was prepared from RAW 264.7 macrophages pre-treated
with MAPK or NF-jB inhibitor. Cells were then treated with CM for 24 h. (A) PDCD4
protein, (B) PDCD4 mRNA and, (C) miR-21 level was measured as in Fig. 4. Values
represent fold increase compared to control and are expressed as mean ± S.E.M.
(n = 3). ⁄P < 0.05 compared with cells treated with control media, #P < 0.05
compared with cells treated with CM without inhibitors.
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to generate pro-inﬂammatory responses both in vivo and in vitro
[6,12,13]. Adiponectin and the miR-21/PDCD4 axis share many bio-
logical responses in common. For example, both activation of the
miR-21/PDCD4 axis and adiponectin play protective roles against
LPS toxicity and inﬂammatory disease by modulating cytokine
expression [6,9,15]. Even if adiponectin and PDCD4 share various
biological roles in common, their relationship has not been demon-
strated. The present study was undertaken to explore the effect of
adiponectin on the regulation of PDCD4 and miR-21, a negative
regulator of PDCD4. Herein, we demonstrate that globular adipo-
nectin (gAcrp) decreases PDCD4 expression, while increases miR-
21 expression through ERK and JNK/NF-jB pathways in RAW
264.7 macrophages. In addition, modulation of miR-21 and PDCD4
by gAcrp involves paracrine manner and JNK/NF-jB pathway plays
a critical role for this process. To our knowledge, this is the ﬁrst re-
port to present the effect of adiponectin on the regulation of miR-
21/PDCD4 axis and data presented here raise a possibility that the
miR-21/PDCD4 axis mediates adiponectin-induced biological
responses.
MicroRNAs bind to target mRNA, causing translation inhibition
or degradation of the mRNA of target proteins. In case of miR-21,
the seed sequence of miR-21 shows perfect complementarity to
PDCD4 30-UTR region, which is conserved among various species,
and a growing body of evidence has demonstrated that miR-21
suppresses expression of PDCD4 in various experimental condi-
tions [6,8,13,17]. Previous studies have shown that ERK1/2 [18],
JNK [19] and NF-jB [6,17] pathways are involved in decreased
PDCD4 level but induce miR-21 expression [6,20]. Adiponectin is
reported to activate ERK1/2, JNK and NF-jB in RAW 264.7 macro-
phages in generation of anti-inﬂammatory activities [16]. Consis-
tent with those reports, we found that gAcrp increased miR-21
and decreased PDCD4 expression via ERK, JNK/NF-jB pathways
(Fig. 3), demonstrating that ERK and JNK/NF-jB are implicated in
both induction of miR-21 and suppression of PDCD4 in various
condition. Due to a problem in transfecting RAW 264.7 macro-phages with miR-21 antisense oligonucleotide we could not pro-
vide direct evidence for the role of miR-21 in the suppression of
PDCD4 by gAcrp. However, based on previous literature and evi-
dence from the implicated identical signaling pathways (Figs. 3
and 5), we suggest that the decrease in PDCD4 level by gAcrp might
be mediated, at least in part, via miR-21.
During the anti-inﬂammatory process by gAcrp, TNF-a expres-
sion initially increases. This, in turn, leads to production of inter-
leukin-10 (IL-10), a key anti-inﬂammatory cytokine which ﬁnally
dampens TLR4 signaling and subsequently inhibits the inﬂamma-
tory response by LPS, implying that the initial inﬂammatory activ-
ity of adiponectin initiates subsequent anti-inﬂammatory activity
by adiponectin [15]. However, detailed mechanisms for switching
of inﬂammatory activity of adiponectin into anti-inﬂammatory
activity remains elusive. It has been suggested that miRNAs may
act as a switch from early pro-inﬂammatory to anti-inﬂammatory
activities of macrophages [21]. Speciﬁcally, previous studies have
shown that inﬂammatory conditions induce expression of miR-
21, which subsequently causes suppression of PDCD4 expression
in RAW 264.7 macrophages [6]. Furthermore, the miR-21/PDCD4
A. Subedi et al. / FEBS Letters 587 (2013) 1556–1561 1561axis has been shown to increase expression of IL-10 [6]. In the cur-
rent study, we demonstrated that adiponectin induces an increase
in miR-21 expression and PDCD4 suppression. Therefore, it is
highly possible that the miR-21/PDCD4 axis may act as a switch
to tune early inﬂammatory activities of adiponectin to anti-inﬂam-
matory activities by increasing IL-10 expression. The role of the
miR-21/PDCD4 axis in the anti-inﬂammatory activity of adiponec-
tin, particularly its role in the generation of tolerance to LPS expo-
sure, is under investigation.
In the present study, we demonstrated that conditioned media
(CM) collected from gAcrp-stimulated RAW 264.7 macrophages
had similar effects on the expressions of miR-21 and PDCD4
(Fig. 4) as that of direct gAcrp treatment. In this experiment, it is
possible that gAcrp was engulfed by macrophages during treat-
ment with macrophages, secreted back into CM and subsequently
this mediated paracrine effect by gAcrp. If paracrine effect were
due to carryover gAcrp in CM, there would be no restoration of
PDCD4 or miR-21 by CM collected from RAW 264.7 macrophages
treated with JNK and NF-jB inhibitor. However, CM from JNK
and NF-jB inhibitor affected PDCD4 and miR-21 expression by
CM (Fig. 5). Thus these results rule out the possibility that carry-
over gAcrp in CM modulates paracrine effect, instead other secre-
tory mediators existing in CM may mediate paracrine effect by
gAcrp. At this stage we could not identify speciﬁc mediators mod-
ulating this paracrine effect. Previous studies have shown that
inﬂammatory conditions increase miR-21 and down-regulate
PDCD4 expression [6,19]. Furthermore, adiponectin initially in-
duces inﬂammatory cytokines which later cause anti-inﬂamma-
tory activity [15]. Hence we speculate that interaction of pro-
inﬂammatory mediators secreted by gAcrp with the nearby cells,
probably through speciﬁc receptors, contributes to induction of
miR-21 and suppression of PDCD4. The effect of gAcrp (and condi-
tioned media) on the regulation of the miR-21/PDCD4 axis was not
observed in other types of cells, such as human hepatoma cell line
(Figs. 1C and 4A) and intestinal epithelial cell line (HT-29) (data not
shown), indicating that gAcrp regulates the miR-21/PDCD4 axis in
a cell speciﬁc manner. We speculate that the lack of effect in other
types of cells may be due to the lack of machineries for responding
to mediators in CM. It would be interesting to identify the speciﬁc
inﬂammatory mediator(s) implicated in adiponectin-induced regu-
lation of the miR-21/PDCD4 axis.
In conclusion, the data presented here demonstrate for the ﬁrst
time that globular adiponectin increases expression of miR-21
while decrease PDCD4 through the MAPK/NF-jB pathway in
RAW 264.7 macrophages. Based on data presented here and in pre-
vious reports, we suggest that miR-21/PDCD4 axis would be a no-
vel promising target implicated in various adiponectin-induced
biological responses. Further studies exploring the role of the
miR-21/PDCD4 axis in adiponectin-induced biological activities
would be valuable to understand the mechanisms implicated in a
number of protective roles of adiponectin.
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